Division of Pediatric Infectious Diseases, Stanford University School of Medicine, Palo Alto, California.
Division of Pediatric Infectious Diseases, UCSF Benioff Children's Hospital Oakland and Children's Hospital Oakland Research Institute, Oakland, California.
Am J Trop Med Hyg. 2018 Apr;98(4):1046-1050. doi: 10.4269/ajtmh.16-0813. Epub 2018 Feb 22.
(SP) is a leading cause of child mortality globally, killing around half a million children aged 5 years and less per year. Nasopharyngeal carriage of SP is a prerequisite to disease, and the prevalence of colonization reaches 100% within the first few years of life. Serotype prevalence varies geographically, impacting the serotype coverage of pneumococcal vaccines, and serotype prevalence data are limited from large regions of the world, including sub-Saharan Africa. We enrolled 323 unvaccinated children, aged 4-7 years from coastal Kenya and obtained nasopharyngeal swab samples before and after vaccination with the 10-valent pneumococcal vaccine. Vaccination did not reduce the overall prevalence of pneumococcal carriage in our cohort, with 65 (20%) children colonized before vaccination and 63 (19.4%) colonized postvaccination. However, the prevalence of vaccine-included serotypes (vaccine strains) declined from 43% to 19% of positive swabs, whereas non-vaccine serotypes increased from 46% to 73%. This study contributes to the few data available regarding pneumococcal carriage and serotype prevalence in Kenya and is in concordance with reports of dynamic serotype replacement, driven by vaccine pressure.
(SP)是全球儿童死亡的主要原因,每年导致约 50 万名 5 岁以下儿童死亡。SP 的鼻咽携带是发病的前提条件,在生命的最初几年,定植的流行率达到 100%。血清型流行率在地理上有所不同,影响了肺炎球菌疫苗的血清型覆盖率,而且包括撒哈拉以南非洲在内的世界上许多地区的血清型流行率数据有限。我们招募了 323 名未接种疫苗的肯尼亚沿海地区 4-7 岁儿童,在接种 10 价肺炎球菌疫苗前后采集鼻咽拭子样本。接种疫苗并没有降低我们队列中肺炎球菌定植的总体流行率,65 名(20%)儿童在接种前定植,63 名(19.4%)儿童在接种后定植。然而,疫苗包含的血清型(疫苗株)的流行率从阳性拭子的 43%下降到 19%,而非疫苗血清型的流行率从 46%上升到 73%。这项研究为肯尼亚的肺炎球菌定植和血清型流行率提供了为数不多的数据,与疫苗压力驱动的血清型动态替代的报告一致。